Press Releases

NEW YORK, Sept. 16, 2019 /PRNewswire/ -- The respected peer-reviewed, medical journal The Lancet will publish today the results of a study presented in May at the National Kidney Foundation's 2019 Spring Clinical Meetings as a late breaking clinical trial that may offer hope to some patients with advanced chronic kidney disease (CKD) whose hypertension is di

HOUSTON, Sept. 16, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced its sponsored research at MD Anderson Cancer Center has resulted in the filing of a new patent on behalf of MD Anderson Ca

ROCKVILLE, Md., Sept. 16, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products, announces that the Chinese National Medical Product Administration (NMPA), the Chinese FDA, has accepted the clinical trial application for CNCT19 (

HighlightsAdAlta secures commercial agreement for its i-body platform with global medical technology and diagnostics firm, GE Healthcare. Under the licensing deal, the two companies will develop i-bodies for diagnostic imaging. AdAlta will screen its novel i-body library on a number of targets in order to identify i-bodies that GE can use as imaging agents, starting with Granzyme B.

SUNNYVALE, Calif., Sept. 16, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, on September 11, 2019, China's Customs Tariff Commission of the State Council issued a tariff exemption for medical linear accelerators.  The tariff exemption, which will be effective

ADELAIDE, Australia, Sept. 16, 2019 /PRNewswire/ -- At the 18th Human Proteome Organization World Congress (www.hupo2019.org), Bruker (Nasdaq: BRKR) today announced the release of the diaPASEF wo

STOCKHOLM, Sept. 16, 2019 /PRNewswire/ -- Atlas Antibodies AB, a leading supplier of advanced research reagents, announced today the introduction of pre-quantified QPrEST™ Protein Standards for absolute quantification of proteins in biological samples such as cell lysate and plasma using liquid chromatography (LC)–mass spectrometry (MS).QPrESTs consis

SAN RAMON, Calif., Sept. 16, 2019 /PRNewswire/ -- BioVentrix, Inc., a pioneer of technologies and procedures for the less invasive treatment of heart failure (HF), announced today that

SINGAPORE, Sept. 16, 2019 /PRNewswire/ -- AIA Group Limited ("AIA"; or the "Company"; stock code: 1299) today unveiled an ambitious new initiative designed to help combat sleep deprivation - a critical health issue in Asia. The initiative, underpinned by a call to action in the form of #OneMoreHour, will raise awareness about the he

NAPLES, Fla., Sept. 16, 2019 /PRNewswire/ -- A simple, quick cure for Alzheimer's disease (AD) will be a "medical miracle", but will also slash $67 billion of revenue from nursing home operators and assisted living companies, plus cause the loss of 654,000 nursing home jobs, predicts Leslie Norins, M.D.,